Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletionLeila Amini, Mohamed Abou‐El‐Enein, Sara Silbert et al.|Nature Reviews Clinical Oncology|2022Cited by 324
Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignanciesTania Jain, Sham Mailankody, Yunxin Chen et al.|Blood Advances|2020Cited by 264
Clinical Responses and Pharmacokinetics of MCARH171, a Human-Derived Bcma Targeted CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma: Final Results of a Phase I Clinical TrialSham Mailankody, Eric L. Smith, Arnab Ghosh et al.|Blood|2018Cited by 100
Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agentsLindsey E. Roeker, Anthony R. Mato, Peter Dreger et al.|Blood Advances|2020Cited by 86
Allogeneic transplant following CAR T-cell therapy for large B-cell lymphomaJoanna Zurko, Alex F. Herrera, Jeremy Ramdial et al.|Haematologica|2022Cited by 73